Kimberly-Clark Completes Spin-Off Of Halyard Health
This article was originally published in The Gray Sheet
Executive Summary
The parts of Kimberly-Clark that are now Halyard had about $1.7 billion in sales of surgical and infection prevention products and other medical devices in 2013.
You may also be interested in...
Kimberly-Clark Facing Multiple Suits On Gown Issues
A California court is allowing a class-action case filed by health-care professionals against the company to go forward, while competitor Medline files suit alleging false advertising. Kimberly-Clark allegedly promoted its MicroCool and Ultra surgical gowns as meeting high safety standards, even though they failed lab testing.
People Briefs
EnteroMedics appoints president and CEO; former Medtronic chair elected to Halyard Health Board of Directors; T2 Biosystems names chief commercial officer; AngioDynamics CFO transition; new Merit Medical Systems CFO tapped.
Kimberly-Clark Set To Spin-Off Medical Biz With Device, Infection-Prevention Focus
The new company, set to launch on Nov. 1 as Halyard Health, will focus on products intended to stop hospital acquired infections as well as pain, respiratory, and digestive health devices.